Fundz

Autonomix Medical Appoints Julie Manchester as VP Regulatory Affairs and Quality

PUBLIC · AMIXFeb 06, 2025

Position

Vice President of Quality

Company

Autonomix Medical

Julie Manchester
jmanchester@autonomix.com
The WoodlandsBiotechnologyHealth CareMedicalMedical Device

Description

Autonomix Medical has appointed Julie Manchester as vice president, Regulatory Affairs and Quality. Julie Manchester is a biotech/medical device executive with over 15 years of quality and regulatory experience within the medical device, cosmetics, pharmaceutical, and product testing industries. The company has completed its animal testing and design lock for its RF technology and is building the required team and infrastructure to support its clinical and regulatory initiatives necessary for the US Food and Drug Administration (FDA) approval process.

Other recent leadership changes in Medical and Medical Device

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Autonomix Medical, and when

A new leader at Autonomix Medical brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Autonomix Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Autonomix Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Autonomix Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Autonomix Medical

Location

The Woodlands, Texas, United States

About

Autonomix (Nasdaq: AMIX) is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Autonomix Medical changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

David
Senior decision-maker at this company
••••••••@••••••••

See David's verified email →

Julie
Likely contact at this company
••••••••@••••••••

See Julie's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Autonomix Medical's next move

Learn about Strategic plan

Autonomix Medical changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.